Estrategias Combinadas en Inmunoterapia Traslacional
ITC
Complejo Hospitalario de Toledo
Toledo, EspañaPublikationen in Zusammenarbeit mit Forschern von Complejo Hospitalario de Toledo (3)
2024
-
Case–control study assessing the impact of COVID19 in advanced kidney cancer patients treated with antiangiogenics or immunotherapy: the COVID-REN study
Clinical and Translational Oncology, Vol. 26, Núm. 3, pp. 732-738
2022
-
Molecular Biomarkers of Prognosis in Advanced Renal Cell Carcinoma Patients Treated With Pazopanib Plus Interferon Alpha (INF-2A) in a Phase I/II Study by the Spanish Oncology Genitourinary Group
Clinical Genitourinary Cancer, Vol. 20, Núm. 4, pp. 388.e1-388.e10
2014
-
Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours
Clinical and Translational Oncology, Vol. 16, Núm. 3, pp. 322-329